By the end of 2027, driven by the demand to scale hyper-personalised patient experiences, improve collaboration, and foster equity, 60% of Asia/Pacific healthcare organisations will double GenAI investments, according to an IDC report.
Elevate Your Tech Prowess with High-Value Skill Courses
| Offering College | Course | Website |
|---|---|---|
| IIM Lucknow | IIML Executive Programme in FinTech, Banking & Applied Risk Management | Visit |
| IIT Delhi | IITD Certificate Programme in Data Science & Machine Learning | Visit |
| IIM Kozhikode | IIMK Advanced Data Science For Managers | Visit |
GenAI is emerging as a transformative force in healthcare and is set to impact workforce efficiency and hyper-personalisation in the care processes.
“With the advent of GenAI and the need for consumerization of care, the next five years are set to be the defining period for the healthcare sector, and we are currently at the starting point of this exciting journey,” said Manoj Vallikkat, senior research manager, healthcare insights, IDC Asia/Pacific.
Driven by the need for improved diagnostic accuracy, speed, and workflow efficiency, care providers in Asia/Pacific will see a 60% increase in AI solution adoption by 2026.
By 2027, 50% of the healthcare industry in Asia/Pacific will leverage GenAI to address data and workflow fragmentation across care settings to improve diagnosis and patient safety to scale care anywhere, the report mentioned.
Discover the stories of your interest
By 2026, a doubling of hospital-at-home patients will propel a 55% growth in investments in tech-enabled integrated care initiatives to address patient safety, workforce, and care access concerns in Asia/Pacific.”In the healthcare sector, the unique risks associated with AI are significant, which necessitates a greater focus on explainability and data security,” added Vallikkat.